Xeris Pharmaceuticals has teamed up with the American Diabetes Association (ADA) to raise awareness of the importance of ...

adding that it had mutually agreed with Xeris BioPharma to return the rights to Ogluo - a ready-to-use glucagon auto-injector for severe hypoglycemia. The AIM-traded firm said the decision ...

This policy applies to all staff, faculty, and relevant personnel at Colorado College (CC) regarding the acquisition, storage, training, and use of epinephrine auto-injectors in response to Colorado ...

(Nasdaq: XERS) to return the commercial rights to Ogluo®, a glucagon auto-injector pen for severe hypoglycemia. The decision follows a strategic review which highlighted the financial ...

The move comes alongside a mutual decision with Xeris BioPharma Holdings, Inc. (Nasdaq: XERS) to return the commercial rights to Ogluo®, a glucagon auto-injector pen for severe hypoglycemia. The ...